Now showing items 520-539 of 637

      Safety and Efficacy of Tocilizumab 4 or 8 mg/kg in Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019 Pneumonia: A Randomized Clinical Trial. [1]
      Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults [1]
      Safety, Feasibility, and Outcomes of Frequent, Long-Duration Rehabilitation in an Inpatient Rehabilitation Facility After Prolonged Hospitalization for Severe COVID-19: An Observational Study. [1]
      The SARS coronavirus papain like protease can inhibit IRF3 at a post activation step that requires deubiquitination activity [1]
      SARS CoV-2 infection among patients using immunomodulatory therapies [1]
      SARS-CoV attack (severe acute respiratory syndrome) [1]
      SARS-CoV-2 and Acute Cerebrovascular Events: An Overview [1]
      SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation [1]
      SARS-CoV-2 B.1.617 Indian variants: Are electrostatic potential changes responsible for a higher transmission rate? [1]
      SARS-CoV-2 in patients with cancer: possible role of mimicry of human molecules by viral proteins and the resulting anti-cancer immunity [1]
      SARS-CoV-2 infection and paediatric endocrine disorders: Risks and management considerations [1]
      SARS-CoV-2 infection in pediatric patient with hemoglobin SC disease [1]
      SARS-CoV-2 mRNA vaccine induced higher antibody affinity and IgG titers against variants of concern in post-partum vs non-post-partum women. [1]
      SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination. [1]
      SARS-CoV-2 shifting transmission dynamics and hidden reservoirs potentially limit efficacy of public health interventions in Italy [1]
      SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice. [1]
      SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors [1]
      SARS-CoV-2: March toward adaptation [1]
      SARS-CoV-2: Overview and Its Impact on Oral Health [1]
      The Saudi Critical Care Society practice guidelines on the management of COVID-19 in the ICU: Therapy section [1]